Search research articles
Contact Us
Filters
Showing results (511-520 of 579) with videos related to
Page
of 58
Sort By:
Nature
|
July 24, 2024
Single-cell multiregion dissection of Alzheimer's disease
Hansruedi Mathys, Carles A Boix, Leyla Anne Akay, et al.
Acta Neuropathologica
|
May 24, 2025
Annexin A6 membrane repair protein protects against amyloid-induced dystrophic neurites and tau phosphorylation in Alzheimer's disease model mice
Katherine R Sadleir, Karen P Gomez, Abigail E Edwards, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 19, 2017
Pharmacological and Toxicological Properties of the Potent Oral <i>γ</i>-Secretase Modulator BPN-15606
Steven L Wagner, Kevin D Rynearson, Steven K Duddy, et al.
Biorxiv : the Preprint Server for Biology
|
January 27, 2025
Molecular hallmarks of excitatory and inhibitory neuronal resilience and resistance to Alzheimer's disease
Isabel Castanho, Pourya Naderi Yeganeh, Carles A Boix, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
August 12, 2024
Biological effects of sodium phenylbutyrate and taurursodiol in Alzheimer's disease
Steven E Arnold, Suzanne Hendrix, Jessie Nicodemus-Johnson, et al.
Alzheimer'S Research & Therapy
|
June 7, 2024
Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer's disease: a randomized, controlled clinical trial
Dean Ornish, Catherine Madison, Miia Kivipelto, et al.
Neuron
|
November 29, 2024
Integrative pathway analysis across humans and 3D cellular models identifies the p38 MAPK-MK2 axis as a therapeutic target for Alzheimer's disease
Pourya Naderi Yeganeh, Sang Su Kwak, Mehdi Jorfi, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 9, 2024
Targeting myeloperoxidase to reduce neuroinflammation in X-linked dystonia parkinsonism
Tiziana Petrozziello, Negin J Motlagh, Ranee Z B Monsanto, et al.
CNS Neuroscience & Therapeutics
|
November 5, 2024
Targeting Myeloperoxidase to Reduce Neuroinflammation in X-Linked Dystonia Parkinsonism
Tiziana Petrozziello, Negin Jalali Motlagh, Ranee Zara B Monsanto, et al.
Neuron
|
June 30, 2001
Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice
R A Cherny, C S Atwood, M E Xilinas, et al.
Page
of 58
Search research articles
Search
Showing results (511-520 of 579) with videos related to
Sort By:
Page
of 58
Nature
|
July 24, 2024
Single-cell multiregion dissection of Alzheimer's disease
Hansruedi Mathys, Carles A Boix, Leyla Anne Akay, et al.
Acta Neuropathologica
|
May 24, 2025
Annexin A6 membrane repair protein protects against amyloid-induced dystrophic neurites and tau phosphorylation in Alzheimer's disease model mice
Katherine R Sadleir, Karen P Gomez, Abigail E Edwards, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 19, 2017
Pharmacological and Toxicological Properties of the Potent Oral <i>γ</i>-Secretase Modulator BPN-15606
Steven L Wagner, Kevin D Rynearson, Steven K Duddy, et al.
Biorxiv : the Preprint Server for Biology
|
January 27, 2025
Molecular hallmarks of excitatory and inhibitory neuronal resilience and resistance to Alzheimer's disease
Isabel Castanho, Pourya Naderi Yeganeh, Carles A Boix, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
August 12, 2024
Biological effects of sodium phenylbutyrate and taurursodiol in Alzheimer's disease
Steven E Arnold, Suzanne Hendrix, Jessie Nicodemus-Johnson, et al.
Alzheimer'S Research & Therapy
|
June 7, 2024
Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer's disease: a randomized, controlled clinical trial
Dean Ornish, Catherine Madison, Miia Kivipelto, et al.
Neuron
|
November 29, 2024
Integrative pathway analysis across humans and 3D cellular models identifies the p38 MAPK-MK2 axis as a therapeutic target for Alzheimer's disease
Pourya Naderi Yeganeh, Sang Su Kwak, Mehdi Jorfi, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 9, 2024
Targeting myeloperoxidase to reduce neuroinflammation in X-linked dystonia parkinsonism
Tiziana Petrozziello, Negin J Motlagh, Ranee Z B Monsanto, et al.
CNS Neuroscience & Therapeutics
|
November 5, 2024
Targeting Myeloperoxidase to Reduce Neuroinflammation in X-Linked Dystonia Parkinsonism
Tiziana Petrozziello, Negin Jalali Motlagh, Ranee Zara B Monsanto, et al.
Neuron
|
June 30, 2001
Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice
R A Cherny, C S Atwood, M E Xilinas, et al.
Page
of 58